Details for New Drug Application (NDA): 020478
✉ Email this page to a colleague
The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for 020478
Tradename: | ULTANE |
Applicant: | Abbvie |
Ingredient: | sevoflurane |
Patents: | 0 |
Pharmacology for NDA: 020478
Physiological Effect | General Anesthesia |
Suppliers and Packaging for NDA: 020478
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ULTANE | sevoflurane | LIQUID;INHALATION | 020478 | NDA | AbbVie Inc. | 0074-4456 | 0074-4456-51 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-51) |
ULTANE | sevoflurane | LIQUID;INHALATION | 020478 | NDA | AbbVie Inc. | 0074-4456 | 0074-4456-04 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | LIQUID;INHALATION | Strength | 100% | ||||
Approval Date: | Jun 7, 1995 | TE: | AN | RLD: | Yes |
Expired US Patents for NDA 020478
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | ULTANE | sevoflurane | LIQUID;INHALATION | 020478-001 | Jun 7, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ULTANE | sevoflurane | LIQUID;INHALATION | 020478-001 | Jun 7, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ULTANE | sevoflurane | LIQUID;INHALATION | 020478-001 | Jun 7, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription